SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Aldeyra Therapeutics Q1 EPS $(0.340) Beats $(0.480) Estimate

Aldeyra Therapeutics (NASDAQ:ALDX) reported quarterly losses of $(0.340) per share which beat the analyst consensus estimate of $(0.480) by 29.17 percent. This is a 3.03 percent decrease over losses of $(0.330) per share

Benzinga · 05/07/2020 11:12

Aldeyra Therapeutics (NASDAQ:ALDX) reported quarterly losses of $(0.340) per share which beat the analyst consensus estimate of $(0.480) by 29.17 percent. This is a 3.03 percent decrease over losses of $(0.330) per share from the same period last year.